Open Nav

Please submit your session questions in advance at

Thomas Adams

CEO and Chairman

Trovagene Oncology

Thomas H. Adams has been Chairman of the Board since April 2009. He has served as Chief Executive Officer of Trovagene since June, 2018.

Since June 2005, Dr. Adams has served as a director of IRIS International, Inc., a diagnostics company, and he has served as Chief Technology Officer of IRIS since April 2006. Dr. Adams served as Chairman and Chief Executive Officer of Leucadia Technologies, a privately held medical-device company, from 1998 to April 2006, when Leucadia was acquired by IRIS.

In 1989, Dr. Adams founded Genta, Inc., a publicly held biotechnology company in the field of antisense technology, and served as its Chief Executive Officer until 1997. Dr. Adams founded Gen-Probe, Inc. in 1984 and served as its Chief Executive Officer and Chairman until its acquisition by Chugai Biopharmaceuticals, Inc. in 1989.

This speaker's sessions: